Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Ipilimumab and nivolumab in combination therapy for cancer treatment causes rare and fatal cardiac side effects.
Breast cancer patients with genetic biomarkers may have an increased risk of anthracycline induced heart damage, reveals a study from Indiana University
Adding a novel monoclonal antibody therapy to traditional chemotherapy increased median survival by nearly a year in patients with advanced sarcoma.